Scheme

Invesco India Pharma and Healthcare Fund

Holds 13 companies worth ₹379 Cr in Sept 2026.

Fund house
INVESCOThe fund house that runs this scheme.
AUM
Not reportedAMFI reports no AUM for it.
Largest holding
Max Healthcare Institute LimitedMax Healthcare Institute Limited is 9.6% of this scheme's NAV.
Fund manager
Aditya KhemaniRuns it since 7 Sept 2026, as the fund house dates it.

Holdings^{(Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	13 companies ·	₹ Cr
	Max Healthcare Institute Limited	41.7
	Sun Pharmaceutical Ind Ltd	39.2
	Sai Life Sciences Limited	37.6
	Apollo Hospitals Enterprise Limited	35
	Manipal Health Enterprises Ltd	34.7
	Divi s Laboratories Limited	34.2
	Global Health Limited	30.5
	Dr Agarwal s Health Care Limited	27.5
	Corona Remedies Limited	26.7
	Torrent Pharmaceuticals Limited	21.5
	Glenmark Pharmaceuticals	21.2
	Krishna Institute of Medical Science Ltd	20.6
	Aster DM Healthcare Limited	8.7

Max Healthcare Institute Li…
Sun Pharmaceutical Ind Ltd

Market value of each ticked company in Invesco India Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Max Healthcare Institute Limited	Sun Pharmaceutical Ind Ltd
Sept 2025	₹0 Cr	₹0 Cr
Oct 2025	₹0 Cr	₹0 Cr
Nov 2025	₹0 Cr	₹0 Cr
Dec 2025	₹0 Cr	₹0 Cr
Jan 2026	₹0 Cr	₹0 Cr
Feb 2026	₹0 Cr	₹0 Cr
Mar 2026	₹0 Cr	₹0 Cr
Apr 2026	₹0 Cr	₹0 Cr
May 2026	₹0 Cr	₹0 Cr
Jun 2026	₹0 Cr	₹0 Cr
Jul 2026	₹0 Cr	₹0 Cr
Aug 2026	₹0 Cr	₹0 Cr
Sept 2026	₹41.7 Cr	₹39.2 Cr

Fig. 1.Market value of each ticked company in Invesco India Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	4	29.80

Mid Cap	3	16.43

Small Cap	5	32.80

Unlisted	1	7.98

Cash & others		12.99

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Max Healthcare Institute Limited	Equity	Healthcare Services	4.49L	41.7	9.58
Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	2.16L	39.2	8.99
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	2.46L	37.6	8.63
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	42.8K	35	8.03
Manipal Health Enterprises Ltd	Equity	Healthcare Services	4.9L	34.7	7.98
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	36.8K	34.2	7.85
Global Health Limited	Equity	Healthcare Services	2.23L	30.5	7.00
Dr Agarwal s Health Care Limited	Equity	Healthcare Services	5.75L	27.5	6.32
Corona Remedies Limited	Equity	Pharmaceuticals & Biotechnology	1.28L	26.7	6.13
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	44.7K	21.5	4.93
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	90.7K	21.2	4.86
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	2.76L	20.6	4.72
Aster DM Healthcare Limited	Equity	Healthcare Services	1.24L	8.7	1.99

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.